相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Mepolizumab in adolescents with severe eosinophilic asthma not eligible for omalizumab: one center's early clinical experience
Elise Weir et al.
JOURNAL OF ASTHMA (2020)
Resolvins: Emerging Players in Autoimmune and Inflammatory Diseases
Fereshte Abdolmaleki et al.
CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY (2020)
Biological therapies in inflammatory bowel disease: Beyond anti-TNF therapies
Konstantinos H. Katsanos et al.
CLINICAL IMMUNOLOGY (2019)
Prevalence of psoriatic arthritis in patients with psoriasis: A systematic review and meta-analysis of observational and clinical studies
Farzad Alinaghi et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2019)
Efficacy and safety of ozanimod in multiple sclerosis: Dose-blinded extension of a randomized phase II study
Jeffrey A. Cohen et al.
MULTIPLE SCLEROSIS JOURNAL (2019)
Rheumatoid arthritis treated with 6-months of first-line biologic or biosimilar therapy: an updated systematic review and network meta-analysis
Emma L. Simpson et al.
INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE (2019)
Anti-inflammatory effects of resolvins in diabetic nephropathy: Mechanistic pathways
Habib Yaribeygi et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2019)
A review of dupilumab in the treatment of atopic diseases
Quinn Thibodeaux et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2019)
Adherence to oral disease-modifying therapy in multiple sclerosis patients: A systematic review
Ee Ling Yoon et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2019)
Benralizumab: A New Approach for the Treatment of Severe Eosinophilic Asthma
Davila Gonzalez I et al.
JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY (2019)
Alemtuzumab as rescue therapy in case of multiple sclerosis rebound following Natalizumab break: Clinical case and literature review
Lisa Federle et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2019)
Systematic review of clinical prediction models to support the diagnosis of asthma in primary care
Luke Daines et al.
NPJ PRIMARY CARE RESPIRATORY MEDICINE (2019)
A comprehensive review of rituximab therapy in rheumatoid arthritis patients
Soheil Tavakolpour et al.
CLINICAL RHEUMATOLOGY (2019)
Targeting immune cell circuits and trafficking in inflammatory bowel disease
Markus F. Neurath
NATURE IMMUNOLOGY (2019)
Resolution of ulcerative colitis
Markus F. Neurath et al.
SEMINARS IN IMMUNOPATHOLOGY (2019)
Epidemiology of Asthma in Children and Adults
Shyamaii C. Dharmage et al.
FRONTIERS IN PEDIATRICS (2019)
Resolution of Crohn's disease
Heike Schmitt et al.
SEMINARS IN IMMUNOPATHOLOGY (2019)
Short-Term Efficacy and Safety of IL-17, IL-12/23, and IL-23 Inhibitors Brodalumab, Secukinumab, Ixekizumab, Ustekinumab, Guselkumab, Tildrakizumab, and Risankizumab for the Treatment of Moderate to Severe Plaque Psoriasis: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials
Fan Bai et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2019)
Safety and efficacy of ozanimod versus interferon beta-1a in relapsing multiple sclerosis (RADIANCE): a multicentre, randomised, 24-month, phase 3 trial
Jeffrey A. Cohen et al.
LANCET NEUROLOGY (2019)
Safety and efficacy of ozanimod versus interferon beta-1a in relapsing multiple sclerosis (SUNBEAM): a multicentre, randomised, minimum 12-month, phase 3 trial
Giancarlo Comi et al.
LANCET NEUROLOGY (2019)
Resolution of acute intestinal graft-versus-host disease
Sindhu Thiagarajan et al.
SEMINARS IN IMMUNOPATHOLOGY (2019)
Resolution of plaque-type psoriasis: what is left behind (and reinitiates the disease)
Theresa Benezeder et al.
SEMINARS IN IMMUNOPATHOLOGY (2019)
Resolution in bullous pemphigoid
Christian D. Sadik et al.
SEMINARS IN IMMUNOPATHOLOGY (2019)
Resolution of inflammation during multiple sclerosis
F. Ruiz et al.
SEMINARS IN IMMUNOPATHOLOGY (2019)
Towards a pro-resolving concept in systemic lupus erythematosus
Sebastian Boeltz et al.
SEMINARS IN IMMUNOPATHOLOGY (2019)
Resolution of inflammation in arthritis
Georg Schett
SEMINARS IN IMMUNOPATHOLOGY (2019)
Resolution of neuroinflammation: mechanisms and potential therapeutic option
Nikolaos Dokalis et al.
SEMINARS IN IMMUNOPATHOLOGY (2019)
The resolution of inflammation through omega-3 fatty acids in atherosclerosis, intimal hyperplasia, and vascular calcification
Miguel Carracedo et al.
SEMINARS IN IMMUNOPATHOLOGY (2019)
Efferocytosis Fuels Requirements of Fatty Acid Oxidation and the Electron Transport Chain to Polarize Macrophages for Tissue Repair
Shuang Zhang et al.
CELL METABOLISM (2019)
Relationship Between Benralizumab Exposure and Efficacy for Patients With Severe Eosinophilic Asthma
Yen Lin Chia et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2019)
Efferocytosis capacities of blood monocyte-derived macrophages in systemic sclerosis
Alice Ballerie et al.
IMMUNOLOGY AND CELL BIOLOGY (2019)
DEL-1 promotes macrophage efferocytosis and clearance of inflammation
Ioannis Kourtzelis et al.
NATURE IMMUNOLOGY (2019)
Safety of combination therapy with two bDMARDs in patients with rheumatoid arthritis: A systematic review and meta-analysis
Goncalo Boleto et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2019)
Chronic Inflammation in Rheumatoid Arthritis and Mediators of Skeletal Muscle Pathology and Physical Impairment: A Review
Beatriz Y. Hanaoka et al.
ARTHRITIS CARE & RESEARCH (2019)
Eicosanoids derived from cytochrome P450 pathway of arachidonic acid and inflammatory shock
Bahar Tunctan et al.
PROSTAGLANDINS & OTHER LIPID MEDIATORS (2019)
Histologic Healing Rates of Medical Therapies for Ulcerative Colitis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Robert Battat et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2019)
Impact of belimumab on patient-reported outcomes in systemic lupus erythematosus: review of clinical studies
Elvira Bangert et al.
PATIENT-RELATED OUTCOME MEASURES (2019)
Mepolizumab for Treating Severe Eosinophilic Asthma: An Evidence Review Group Perspective of a NICE Single Technology Appraisal
Inigo Bermejo et al.
PHARMACOECONOMICS (2018)
Inflammation and immune resolution
Leonie S. Taams
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2018)
Recent developments in systemic lupus erythematosus pathogenesis and applications for therapy
Mindy S. Lo et al.
CURRENT OPINION IN RHEUMATOLOGY (2018)
International validation of the consensus Immunoscore for the classification of colon cancer: a prognostic and accuracy study
Franck Pages et al.
LANCET (2018)
Reslizumab for Treating Asthma with Elevated Blood Eosinophils Inadequately Controlled by Inhaled Corticosteroids: An Evidence Review Group Perspective of a NICE Single Technology Appraisal
Keith Cooper et al.
PHARMACOECONOMICS (2018)
A comprehensive review on the role of co-signaling receptors and Treg homeostasis in autoimmunity and tumor immunity
Prabhakaran Kumar et al.
JOURNAL OF AUTOIMMUNITY (2018)
Resolution of chronic inflammatory disease: universal and tissue-specific concepts
Georg Schett et al.
NATURE COMMUNICATIONS (2018)
The crucial roles of inflammatory mediators in inflammation: A review
L. A. Abdulkhaleq et al.
VETERINARY WORLD (2018)
Pro-resolving mediators promote resolution in a human skin model of UV-killed Escherichia coli-driven acute inflammation
Madhur P. Motwani et al.
JCI INSIGHT (2018)
Clinical utility of ustekinumab in Crohn's disease
Paulo Gustavo Kotze et al.
JOURNAL OF INFLAMMATION RESEARCH (2018)
Risankizumab in patients with moderate to severe Crohn's disease: an open-label extension study
Brian G. Feagan et al.
LANCET GASTROENTEROLOGY & HEPATOLOGY (2018)
Treating inflammation and infection in the 21st century: new hints from decoding resolution mediators and mechanisms
Charles N. Serhan
FASEB JOURNAL (2017)
Pathogenetic insights from the treatment of rheumatoid arthritis
Iain B. McInnes et al.
LANCET (2017)
Induction therapy with the selective interleukin-23 inhibitor risankizumab in patients with moderate-to-severe Crohn's disease: a randomised, double-blind, placebo-controlled phase 2 study
Brian G. Feagan et al.
LANCET (2017)
Certolizumab Pegol: A Review in Inflammatory Autoimmune Diseases
Emma D. Deeks
BIODRUGS (2016)
Integrative Analyses of Colorectal Cancer Show Immunoscore Is a Stronger Predictor of Patient Survival Than Microsatellite Instability
Bernhard Mlecnik et al.
IMMUNITY (2016)
New insights into the immunopathogenesis of systemic lupus erythematosus
George C. Tsokos et al.
NATURE REVIEWS RHEUMATOLOGY (2016)
Ustekinumab as Induction and Maintenance Therapy for Crohn's Disease
B. G. Feagan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
T helper 9 cells induced by plasmacytoid dendritic cells regulate interleukin-17 in multiple sclerosis
Gabriella Ruocco et al.
CLINICAL SCIENCE (2015)
IL-10 and Regulatory T Cells Cooperate in Allergen-Specific Immunotherapy To Ameliorate Allergic Asthma
Livia Bohm et al.
JOURNAL OF IMMUNOLOGY (2015)
Subcutaneous Golimumab Induces Clinical Response and Remission in Patients With Moderate-to-Severe Ulcerative Colitis
William J. Sandborn et al.
GASTROENTEROLOGY (2014)
Macrophage-Restricted Interleukin-10 Receptor Deficiency, but Not IL-10 Deficiency, Causes Severe Spontaneous Colitis
Ehud Zigmond et al.
IMMUNITY (2014)
New targets for mucosal healing and therapy in inflammatory bowel diseases
M. F. Neurath
MUCOSAL IMMUNOLOGY (2014)
Secukinumab in Plaque Psoriasis - Results of Two Phase 3 Trials
Richard G. Langley et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Chronic Inflammation and Cytokines in the Tumor Microenvironment
Glauben Landskron et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2014)
Cytokines in inflammatory bowel disease
Markus F. Neurath
NATURE REVIEWS IMMUNOLOGY (2014)
Adalimumab prevents barrier dysfunction and antagonizes distinct effects of TNF-α on tight junction proteins and signaling pathways in intestinal epithelial cells
Andreas Fischer et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2013)
Toward a cytokine-based disease taxonomy
Georg Schett et al.
NATURE MEDICINE (2013)
Vedolizumab as Induction and Maintenance Therapy for Ulcerative Colitis
Brian G. Feagan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Secukinumab, a human anti-IL-17A monoclonal antibody, for moderate to severe Crohn's disease: unexpected results of a randomised, double-blind placebo-controlled trial
Wolfgang Hueber et al.
GUT (2012)
Anti-Interleukin-17 Monoclonal Antibody Ixekizumab in Chronic Plaque Psoriasis
Craig Leonardi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Tofacitinib, an Oral Janus Kinase Inhibitor, in Active Ulcerative Colitis
William J. Sandborn et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Ustekinumab Induction and Maintenance Therapy in Refractory Crohn's Disease
William J. Sandborn et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
MEDICAL PROGRESS Ulcerative Colitis
Silvio Danese et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Inflammation and Colon Cancer
Janos Terzic et al.
GASTROENTEROLOGY (2010)
Predicting the response to infliximab from trough serum levels
Paul Rutgeerts et al.
GUT (2010)
Tocilizumab: An Interleukin-6 Receptor Inhibitor for the Treatment of Rheumatoid Arthritis
Susyn L. Plushner
ANNALS OF PHARMACOTHERAPY (2008)
IL-4 inhibits TGF-β-induced Foxp3+ T cells and, together with TGF-β, generates IL-9+ IL-10+ Foxp3- effector T cells
Valerie Dardalhon et al.
NATURE IMMUNOLOGY (2008)
TREM-1-expressing intestinal macrophages crucially amplify chronic inflammation in experimental colitis and inflammatory bowel diseases
Mirjam Schenk et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Adalimumab for maintenance of clinical response and remission in patients with Crohn's disease: The CHARM trial
Jean-Frederic Colombel et al.
GASTROENTEROLOGY (2007)
Characterization of Foxp3+CD4+CD25+ and IL-10-secreting CD4+CD25+ T cells during cure of colitis
Holm H. Uhlig et al.
JOURNAL OF IMMUNOLOGY (2006)
Transforming growth factor β induced FoxP3+ regulatory T cells suppress Th1 mediated experimental colitis
MC Fantini et al.
GUT (2006)
Methylene blue-aided chromoendoscopy for the detection of intraepithelial neoplasia and colon cancer in ulcerative colitis
R Kiesslich et al.
GASTROENTEROLOGY (2003)
分享论文
